IL15 and neoplasm: This tumor-rejection antigen encoded by endogenous retroviruses is also expressed in human tumors (43) and while it may be hard to identify T cells specific for these epitopes, after vvDD-IL15/Rα infection these T cells may be abundant and applicable for ACT.